evalu vitro bromodeoxyuridin label breast carcinoma use commerci kit prognost signific s-phase fraction analys breast carcinoma sever investig cell prolifer kit amersham corpor arlington height IL vitro bromodeoxyuridin brdu cell cycl kinet flow cytomet radioisotop simplifi assay clinical-bas laboratori standard reagent method studi data use compar s-phase data use thymidin label brdu method breast carcinoma primari infiltr ductal carcinoma primari lobular carcinoma mean median brdu label rang benign lesion brdu uptak estrogen receptor ER progesteron receptor PR statu brdu s-phase fraction er- pr-neg tumor correl brdu uptak histolog tumor type size signific correl brdu uptak lymph node statu patient age histolog tumor grade s-phase studi breast carcinoma techniqu similar data cell prolifer kit practic use method vitro s-phase analysi concomit histolog examin tumor tissu sampl 